Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?
Public ClinicalTrials.gov record NCT04725357. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Comparison of Meloxicam to Opioids Following Arthroscopic Labrum Repairs of the Shoulder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The opioid epidemic continues to be a major concern, with orthopedic surgeons being among the top prescribers of opioids. Studies evaluating these practices found that opioids are overprescribed, even for common procedures. Patients undergoing arthroscopic labrum repair of the shoulder were found to have an average of 20 pills left over after surgery. Many strategies have been developed to tackle overprescribing and have found success, including no opioid protocols for carpal tunnel release. The purpose of this study is to examine if meloxicam alone provides similar patient reported outcomes to opioids following arthroscopic labrum repair of the shoulder.
Study identification
- NCT ID
- NCT04725357
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 96 participants
Conditions and interventions
Conditions
Interventions
- Meloxicam 15 mg Drug
- Preoperative Interscalene Nerve Block Procedure
- arthroscopic labral repair Procedure
Drug · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 24, 2021
- Primary completion
- Jan 24, 2022
- Completion
- Jan 24, 2022
- Last update posted
- Jan 25, 2021
2021 – 2022
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rothman Orthopaedic Institute | Philadelphia | Pennsylvania | 19107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Shoulder Pain trials
Other public records listing Shoulder Pain. Sorted by last update posted; newest first. Not a recommendation.
- NCT06788717: MDR - Comprehensive Primary Revision Stems PMCF Recruiting
- NCT04984291: Zimmer Biomet Shoulder Arthroplasty PMCF Recruiting
- NCT07421245: OsseoFit Stemless Shoulder System (Anatomic) Not yet recruiting
- NCT07489937: Supraspinatus Tendon Acute Effects After Two Exercise Exposures: a Crossover Randomized Trial. Recruiting
- NCT06039345: Shoulder RFA Pilot Study Active, not recruiting
- NCT03653455: Patient Outcomes Collection: How Can we do Better? Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04725357, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 25, 2021 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04725357 live on ClinicalTrials.gov.